Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

SHA:600976 Revenue

Jianmin Pharmaceutical Group had revenue of 686.12M CNY in the quarter ending September 30, 2026, a decrease of -8.19%. This brings the company's total for the last twelve months to 3.12B, down -1.90% year-over-year. In the year 2025, Jianmin Pharmaceutical Group had annual revenue of 3.37B, down -3.85%. That makes Jianmin Pharmaceutical Group the 11,618th largest company in the world by revenue and 1,958th in China.

• Revenue (ttm): 3.12B
• Revenue Growth: -1.90%
• P/S Ratio: 1.30
• Revenue / Employee: 1.38M
• Employees: 2,257
• Market Cap: 4.06B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Production and Sales 3.80B 73.5%
• Commercial 1.37B 26.5%

Fiscal year ended Dec 31, 2025 See the full SHA:600976 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.37B	-135.08M	-3.85%
Dec 31, 2024	3.50B	-708.17M	-16.81%
Dec 31, 2023	4.21B	572.35M	15.72%
Dec 31, 2022	3.64B	341.37M	10.35%
Dec 31, 2021	3.30B	843.43M	34.34%

Data Source: S&P Global Market Intelligence Last updated: Oct 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error